80041758EM - Optimal Management of HIV Disease & Hepatitis Clinical Conference (OPMAN XXV) EM


Date & Location
Tuesday, April 11, 2017 7:00 AM - Tuesday, April 10, 2018 3:00 PM   Baltimore, MD

Specialties
Infectious Diseases, Internal Medicine, Nurse Practitioner, Psychiatry, Public Health

Overview
For the course contents, please click here .



Objectives
  1. Use new information on the pathogenesis of HIV and Viral Hepatitis infection into patient management strategies.
  2. Identify antiretroviral and HBV/HCV antiviral therapies based upon the most recent USPHS, IAS-USA, AASLD, IDSA and EASL Guidelines.
  3. Manage patients with antiretroviral and/or HBV/HCV therapy failure based upon the most recent data presented at CROI (2017), AASLD (2016), Glasgow (2016), International AIDS Conference (2016), ICAAC (2016), IDSA (2016), and EASL (2016) conferences
  4. Use the latest pharmacogenomics/kinetics/dynamics data in managing antiviral (HIV, HBV, HCV) drug interactions, side effects, and complications of treatment.
  5. Evaluate patients for pre-exposure prophylaxis therapy to prevent HIV infection.
  6. Identify and manage patient risk factors for cardiovascular complications of HIV and HIV HBV/HCV co-infected patients.

Accreditation
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.